Santiago Thibaud

11PUBLICATIONS
58CO-AUTHORS
Haematological tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 13, 2025
Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy.

Zachary M Avigan, Jerrel Catlett, Saoirse Bodnar

|Sep 16, 2024
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes.

Santiago Thibaud, Ryan L Subaran, Scott Newman

|May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma.

Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz

|Sep 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups.

Urvi A Shah, Erin Moshier, Andriy Derkach

|Sep 28, 2023
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies.

Guido Lancman, Kian Parsa, Krzysztof Kotlarz

|Nov 03, 2022
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.

Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine

Pageof 2

Frequent Collaborators

9 joint publications

Hearn Jay Cho

8 joint publications

Joshua Richter

8 joint publications

Sundar Jagannath

5 joint publications

Tarek H Mouhieddine